BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10252375)

  • 1. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction reporting: a working system.
    Michelson PA; Shields K
    Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A description of a successful computerized adverse drug reaction tracking program.
    Maliekal J; Thornton J
    Hosp Formul; 1990 Apr; 25(4):436-9, 442. PubMed ID: 10104234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of data collection method on results of serum digoxin concentration audit.
    Makela EH; Davis SK; Piveral K; Miller WA; Pleasants RA; Gadsden RH; Leman RB
    Am J Hosp Pharm; 1988 Jan; 45(1):126-30. PubMed ID: 3348225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions.
    Kennedy LD; Case LD; Hurd DD; Cruz JM; Pomper GJ
    Transfusion; 2008 Nov; 48(11):2285-91. PubMed ID: 18673350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a comprehensive medication reaction reporting system.
    Yee WP; Norton LL; Catania HF
    Hosp Pharm; 1995 May; 30(5):384-5, 389-91, 394-6. PubMed ID: 10142377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a hospital-based adverse drug reaction reporting program.
    Cantú TG; Tyler LS
    Hosp Formul; 1988 Aug; 23(8):658-61. PubMed ID: 10288394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of reporting systems of adverse reactions to drugs and care.
    Jorup-Rönström C; Britton S
    Scand J Soc Med; 1983; 11(3):87-9. PubMed ID: 6669976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital pharmacy program for reporting adverse drug reactions.
    Jacinto MS; Kleinmann K
    Am J Hosp Pharm; 1983 Mar; 40(3):444-5. PubMed ID: 6846353
    [No Abstract]   [Full Text] [Related]  

  • 16. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-based system for adverse drug reaction detection and prevention.
    Tatro DS; Moore TN; Cohen SN
    Am J Hosp Pharm; 1979 Feb; 36(2):198-201. PubMed ID: 420208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly.
    Schmader KE; Hanlon JT; Pieper CF; Sloane R; Ruby CM; Twersky J; Francis SD; Branch LG; Lindblad CI; Artz M; Weinberger M; Feussner JR; Cohen HJ
    Am J Med; 2004 Mar; 116(6):394-401. PubMed ID: 15006588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hereford Hospital Prescribing Study. Investigation of methods to identify patients with adverse drug reactions.
    Alexander AM; Barnett JW; Veitch GB
    J Clin Hosp Pharm; 1981 Sep; 6(3):201-6. PubMed ID: 7298863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.
    Schumock GT; Thornton JP; Witte KW
    Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.